BioCentury
ARTICLE | Finance

How Wellington closed its largest fund yet at €210M

String of exits, well-defined European focus helped Wellington Partners close its fifth and largest fund

July 31, 2019 5:29 AM UTC
Updated on Dec 10, 2019 at 6:50 PM UTC

Takeouts of portfolio companies Rigontec and Symetis, coupled with a focus on biotechs in Germany, Austria and Switzerland, helped Wellington Partners raise its largest fund to date.

Wellington announced Wednesday the close of Wellington Partners Life Science Fund V at €210 million ($233.5 million), well above the fund’s target of €150 million ($166.8 million). The fund is more than double the size of Wellington’s previous fund, WPLS-IV, which closed at €85 million ($113.5 million) in 2013....

BCIQ Company Profiles

Wellington Partners